or
forgot password

    • cancer clinical trials in fayetteville, AR

    • Lymph Node Removal in Treating Women Who Have Stage I or Stage IIA Breast Cancer
    Washington Regional Medical Center
    Fayetteville, Arkansas 72703
    Breast Cancer
    Weekly Infusions of Paclitaxel in Treating Women With Stage III or Stage IV Ovarian Cancer Refractory to Paclitaxel and Platinum
    Highlands Oncology Group, P.A.
    Fayetteville, Arkansas 72703
    Fallopian Tube Cancer, Ovarian Cancer, Primary Peritoneal Cavity Cancer
    Prognostic Study of Sentinel Lymph Node and Bone Marrow Metastases in Women With Stage I or Stage IIA Breast Cancer
    Washington Regional Medical Center
    Fayetteville, Arkansas 72703
    Breast Cancer
    Vinorelbine in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
    Highlands Oncology Group, P.A.
    Fayetteville, Arkansas 72703
    Lung Cancer
    Combination Chemotherapy in Treating Patients With Stage III, Stage IV, or Recurrent Endometrial Cancer
    Highlands Oncology Group - Fayetteville

    Trial Locations
    Highlands Oncology Group - Fayetteville
    Washington Regional Medical Center
    Endometrial Cancer
    Cisplatin and Radiation Therapy With or Without Tirapazamine in Treating Patients With Cervical Cancer
    Washington Regional Medical Center - Fayetteville

    Trial Locations
    Washington Regional Medical Center - Fayetteville
    Highlands Oncology Group PA - Fayetteville
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Stage IB Cervical Cancer, Stage IIA Cervical Cancer, Stage IIB Cervical Cancer, Stage III Cervical Cancer, Stage IVA Cervical Cancer
    Phase 2b Study of Taxol Plus Sorafenib or Placebo in Patients With Advanced Breast Cancer
    Highlands Oncology Group - Fayetteville
    Fayetteville, Arkansas 72703
    Breast Cancer
    Randomized Study Comparing Docetaxel Plus Dasatinib to Docetaxel Plus Placebo in Castration-Resistant Prostate Cancer
    Highlands Oncology Group, P.A.
    Fayetteville, Arkansas 72703
    Prostatic Neoplasms
    Paclitaxel and Cisplatin or Topotecan With or Without Bevacizumab in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
    Washington Regional Medical Center - Fayetteville
    Fayetteville, Arkansas 72703
    Cervical Adenocarcinoma, Cervical Adenosquamous Cell Carcinoma, Cervical Squamous Cell Carcinoma, Recurrent Cervical Cancer, Stage IVB Cervical Cancer
    Study of Immunotherapy to Treat Advanced Prostate Cancer
    Highlands Oncology Group, P.A.
    Fayetteville, Arkansas 72703
    Prostate Cancer
    Everolimus in Combination With Trastuzumab and Paclitaxel in the Treatment of HER2 Positive Locally Advanced or Metastatic Breast Cancer
    Highlands Oncology Group DeptofHighlandsOncologyGrp(2)
    Fayetteville, Arkansas 72703
    Breast Cancer
    Safety and Efficacy of RAD001 (Everolimus) Monotherapy Plus Best Supportive Care in Patients With Advanced Gastric Cancer (AGC)
    Highlands Oncology Group DeptofHighlandsOncologyGrp(2)
    Fayetteville, Arkansas 72703
    Advanced Gastric Cancer
    Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma
    Highlands Oncology Group HighlandsOncGrp-Bentonville(2)
    Fayetteville, Arkansas 72703
    Renal Cell Carcinoma
    BIBW 2992 (Afatinib) Versus Chemotherapy as First Line Treatment in NSCLC With EGFR Mutation
    1200.32.2605 Boehringer Ingelheim Investigational Site
    Fayetteville, Arkansas
    Carcinoma, Non-Small-Cell Lung, Adenocarcinoma
    Safety and Efficacy of BKM120 in Combination With Trastuzumab in Patients With Relapsing HER2 Overexpressing Breast Cancer Who Have Previously Failed Trastuzumab
    Highlands Oncology Group Dept of Highlands Oncology Grp
    Fayetteville, Arkansas 72703
    Metastatic Breast Cancer, Trastuzumab, BKM120, HER2+
    Study of Dovitinib Versus Sorafenib in Patients With Metastatic Renal Cell Carcinoma
    Highlands Oncology Group Dept of Highlands Oncology Grp
    Fayetteville, Arkansas 72703
    Metastatic Renal Cell Carcinoma
    Combination of AUY922 With Trastuzumab in HER2+ Advanced Breast Cancer Patients Previously Treated With Trastuzumab
    Highlands Oncology Group Dept of Highlands Oncology Grp
    Fayetteville, Arkansas 72703
    Advanced HER2-positive Breast Cancer
    BKM120 as Second-line Therapy for Advanced Endometrial Cancer
    Highlands Oncology Group Dept of Highlands Oncology Grp
    Fayetteville, Arkansas 72703
    Advanced Endometrial Cancer
    Safety and Efficacy of BKM120 in Patients With Metastatic Non-small Cell Lung Cancer
    Highlands Oncology Group Dept of Highlands Oncology Grp
    Fayetteville, Arkansas 72703
    Non-small Cell Lung Cancer
    Study of BHQ880 in Patients With High Risk Smoldering Multiple Myeloma
    Highlands Oncology Group Dept of Highlands Oncology Grp
    Fayetteville, Arkansas 72703
    Smoldering Multiple Myeloma
    A Phase II Study of Single Agent MEK162 in Patients With Advanced Melanoma
    Highlands Oncology Group Dept of Highlands Oncology Grp
    Fayetteville, Arkansas 72703
    BRAF or NRAS Mutant Metastatic Melanoma
    A Phase II Study of Efficacy and Safety in Patients With Locally Advanced or Metastatic Basal Cell Carcinoma
    Highlands Oncology Group Dept of Highlands Oncology Grp
    Fayetteville, Arkansas 72703
    Basal Cell Carcinoma
    Dose Finding Study of RAD001 (Everolimus, Afinitor®) in Combination With BEZ235 in Patients With Advanced Solid Tumors
    Highlands Oncology Group Dept of Highlands Oncology Grp
    Fayetteville, Arkansas 72703
    Advanced Solid Tumors, Metastatic Breast Cancer, Metastatic Renal Cell Carcinoma
    Trial Evaluating Dovitinib Combined With Fulvestrant, in Postmenopausal Patients With HER2- and HR+ Breast Cancer
    Highlands Oncology Group Dept of Highlands Oncology Grp
    Fayetteville, Arkansas 72703
    Metastatic Breast Cancer
    A Randomized, Phase 2, Neoadjuvant Study of Weekly Paclitaxel With LCL161 in Patients With Triple Negative Breast Cancer
    Highlands Oncology Group Dept of Highlands Oncology Grp
    Fayetteville, Arkansas 72703
    Breast Cancer
    A Phase III Study of BKM120 With Fulvestrant in Patients With HR+,HER2-, AI Treated, Locally Advanced or Metastatic Breast Cancer Who Progressed on or After mTORi
    Highlands Oncology Group Dept of Highlands Oncology Grp
    Fayetteville, Arkansas 72703
    Metastatic Breast Cancer HR+, HER2-
    LDK378 in Adult Patients With ALK-activated NSCLC Previously Treated With Chemotherapy and Crizotinib
    Highlands Oncology Group Dept of Highlands Oncology Grp
    Fayetteville, Arkansas 72703
    Non-Small Cell Lung Cancer
    LDK378 in Crizotinib naïve Adult Patients With ALK-activated Non-small Cell Lung Cancer
    Highlands Oncology Group Dept of Highlands Oncology Grp
    Fayetteville, Arkansas 72703
    Non-Small Cell Lung Cancer
    Paclitaxel or Docetaxel in Treating Women With Advanced Breast Cancer
    Highlands Oncology Group, P.A. - Fayetteville
    Fayetteville, Arkansas 72703
    Breast Cancer
    Carboplatin Plus Paclitaxel With or Without Continued Low-Dose Paclitaxel in Treating Patients With Early-Stage Ovarian Cancer
    Highlands Oncology Group - Fayetteville

    Trial Locations
    Highlands Oncology Group - Fayetteville
    Washington Regional Medical Center
    Ovarian Cancer
    A Phase 1/2 Study Evaluating ABT-751 in Combination With Alimta in Advanced Non-Small Cell Lung Cancer
    Site Reference ID/Investigator# 3358
    Fayetteville, Arkansas 72703
    Lung Cancer, NSCLC, Non-Small-Cell Lung Cancer
    BI 2536 Second Line Monotherapy in SCLC
    1216.11.007 Boehringer Ingelheim Investigational Site
    Fayetteville, Arkansas
    Carcinoma, Small Cell
    Assessment and Tracking of Long-term Alefacept Safety
    Ozark Dermatology Clinic
    Fayetteville, Arkansas 72703
    Psoriasis
    BIBW 2992 and BSC Versus Placebo and BSC in Non-small Cell Lung Cancer Patients Failing Erlotinib or Gefitinib (LUX-LUNG 1)
    1200.23.046 Boehringer Ingelheim Investigational Site
    Fayetteville, Arkansas
    Carcinoma, Non-Small-Cell Lung
    Safety and Efficacy of RAD001 in Patients With Mantle Cell Lymphoma Who Are Refractory or Intolerant to Velcade® Therapy.
    Highlands Oncology Group DeptofHighlandsOncologyGrp(2)
    Fayetteville, Arkansas 72703
    Lymphoma, Mantle- Cell
    Safety and Efficacy of Bevacizumab Plus RAD001 Versus Interferon Alfa-2a and Bevacizumab in Adult Patients With Kidney Cancer
    Highlands Oncology Group Dept of Highlands Oncology Grp
    Fayetteville, Arkansas 72703
    Carcinoma, Renal Cell, Adenocarcinoma, Renal Cell, Nephroid Carcinoma, Carcinoma, Hypernephroid
    A Study to Assess BHQ880 in Combination With Zoledronic Acid in Relapsed or Refractory Myeloma Patients
    Highlands Oncology Group Dept of Highlands Oncology Grp
    Fayetteville, Arkansas 72703
    Multiple Myeloma Bone Disease
    Study Comparing the Efficacy of MEK162 Versus Dacarbazine in Unresectable or Metastatic NRAS Mutation-positive Melanoma
    Highlands Oncology Group SC
    Fayetteville, Arkansas 72703
    Metastatic or Unresectable Cutaneous Melanoma
    Study of LEE011, BYL719 and Letrozole in Advanced ER+ Breast Cancer
    Highlands Oncology Group Oncology Group
    Fayetteville, Arkansas 72703
    Breast Cancer